JPH10290699A - Production of oil and fat containing triglyceride containing gamma-linolenic acid at high concentration and/or triglyceride containing dihomo-gamma-linolenic acid at high concentration - Google Patents
Production of oil and fat containing triglyceride containing gamma-linolenic acid at high concentration and/or triglyceride containing dihomo-gamma-linolenic acid at high concentrationInfo
- Publication number
- JPH10290699A JPH10290699A JP9116281A JP11628197A JPH10290699A JP H10290699 A JPH10290699 A JP H10290699A JP 9116281 A JP9116281 A JP 9116281A JP 11628197 A JP11628197 A JP 11628197A JP H10290699 A JPH10290699 A JP H10290699A
- Authority
- JP
- Japan
- Prior art keywords
- linolenic acid
- triglyceride
- oil
- acid
- lipase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title claims abstract description 56
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 title claims abstract description 30
- 235000020664 gamma-linolenic acid Nutrition 0.000 title claims abstract description 30
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 229960002733 gamolenic acid Drugs 0.000 title claims abstract description 28
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 title claims abstract description 27
- 235000019197 fats Nutrition 0.000 title claims abstract description 25
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 108090001060 Lipase Proteins 0.000 claims abstract description 35
- 102000004882 Lipase Human genes 0.000 claims abstract description 35
- 239000004367 Lipase Substances 0.000 claims abstract description 35
- 235000019421 lipase Nutrition 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 150000003626 triacylglycerols Chemical group 0.000 claims abstract description 22
- 150000004667 medium chain fatty acids Chemical class 0.000 claims abstract description 17
- 239000003921 oil Substances 0.000 claims description 31
- 238000006243 chemical reaction Methods 0.000 claims description 30
- 239000003925 fat Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 241000195493 Cryptophyta Species 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims 2
- 229960004488 linolenic acid Drugs 0.000 claims 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims 2
- 241000233866 Fungi Species 0.000 claims 1
- 238000004321 preservation Methods 0.000 abstract description 2
- 229940040461 lipase Drugs 0.000 description 29
- 235000019198 oils Nutrition 0.000 description 26
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 16
- 239000002994 raw material Substances 0.000 description 13
- 235000021324 borage oil Nutrition 0.000 description 9
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 229960002446 octanoic acid Drugs 0.000 description 8
- 239000000919 ceramic Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000005809 transesterification reaction Methods 0.000 description 6
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000235575 Mortierella Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 108010093096 Immobilized Enzymes Proteins 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 241000235527 Rhizopus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- -1 saturated fatty acid alcohol ester Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000010497 wheat germ oil Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 101710098556 Lipase A Proteins 0.000 description 1
- 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 1
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000235402 Rhizomucor Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229940094199 black currant oil Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000010701 ester synthesis reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000028201 sequestering of triglyceride Effects 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、γ−リノレン酸高
度含有トリグリセリド及び/またはジホモγ−リノレン
酸高度含有トリグリセリドの製造法に関する。The present invention relates to a method for producing highly γ-linolenic acid-rich triglycerides and / or highly di-homo γ-linolenic acid-rich triglycerides.
【0002】[0002]
【従来の技術】近年、高度不飽和脂肪酸含有トリグセリ
ドの有する生理活性が注目されている。特にγーリノレ
ン酸含有トリグリセリドやジホモγーリノレン酸含有ト
リグリセリドは、アトピー性皮膚炎、慢性関節炎リウマ
チ、高血圧などの成人病に対する改善作用や制癌作用、
免疫賦活作用など多くの生理活性作用を有していること
が知られている。そして、γーリノレン酸含有トリグリ
セリドやジホモγーリノレン酸含有トリグリセリドの医
薬品、特定保健用食品への利用法について様々な検討が
なされている。2. Description of the Related Art In recent years, attention has been paid to the physiological activity of triglycerides containing highly unsaturated fatty acids. In particular, γ-linolenic acid-containing triglycerides and dihomo γ-linolenic acid-containing triglycerides are effective in improving and anticancer effects on adult diseases such as atopic dermatitis, rheumatoid arthritis, and high blood pressure.
It is known to have many physiologically active effects such as immunostimulatory effects. Various studies have been made on the use of γ-linolenic acid-containing triglycerides and dihomo γ-linolenic acid-containing triglycerides in pharmaceuticals and foods for specified health use.
【0003】従来より、高度不飽和脂肪酸の損失を少な
くし、ジグリセリドを副生することなく高度不飽和脂肪
酸を高濃度に含むトリグリセリドを製造する方法が要望
されている。例えば、特開昭63−273485号公報
では、多価不飽和脂肪酸含有油脂と飽和脂肪酸及び又は
飽和脂肪酸アルコールエステルとを特定のリパーゼを用
いて、エステル交換させ、2−位に多価不飽和脂肪酸酸を
有するトリグリセリドを40重量%以上含有し、かつ炭
素数16以上の全飽和脂肪酸含有が50重量%以上であ
る油脂組成物の製法が開示され、また、特開平6−28
7594号公報では、特異的リパーゼを用いたエステル
交換反応を利用して、魚油とオレイン酸を原料とし、
1,3−位にオレイン酸を含有し、2−位にドコサヘキ
サエン酸を含有するトリグリセリドの製造方法が開示さ
れている。更に、特開平8−214891号公報では、
油脂、中鎖脂肪酸の存在下で、トリグリセリドの1,3
−位のエステル結合のみに作用するリパーゼを作用させ
る油脂の製造方法が開示されている。[0003] Conventionally, there has been a demand for a method for producing triglycerides containing highly unsaturated fatty acids at a high concentration without reducing the loss of polyunsaturated fatty acids and by-producing diglycerides. For example, in JP-A-63-273485, a polyunsaturated fatty acid-containing oil and a saturated fatty acid and / or a saturated fatty acid alcohol ester are transesterified with a specific lipase to give a polyunsaturated fatty acid at the 2-position. A method for producing an oil / fat composition containing at least 40% by weight of a triglyceride having an acid and containing at least 50% by weight of a total saturated fatty acid having 16 or more carbon atoms is disclosed.
No. 7,594, using a transesterification reaction using a specific lipase, using fish oil and oleic acid as raw materials,
A method for producing a triglyceride containing oleic acid at the 1,3-position and docosahexaenoic acid at the 2-position is disclosed. Further, in Japanese Patent Application Laid-Open No. Hei 8-214891,
1,3 of triglyceride in the presence of fats and oils, medium chain fatty acids
There is disclosed a method for producing an oil or fat in which a lipase acting only on the -position ester bond acts.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、特開昭
63−273485号公報記載の方法では、トリグリセ
リド中の特定の高度不飽和脂肪酸を高度に濃縮すること
はできないという問題があり、又、特開平6−2875
94号公報記載の方法では、エステル交換に用いるオレ
イン酸が魚油の構成脂肪酸の平均分子量に相当するた
め、トリグリセリド中のγ−リノレン酸含量を高めるこ
とはできず、また、生成油脂中のトリグリセリドの収率
は原料トリグリセリドに対して約90モル%と高いもの
ではなかった。また、特開平8-214891号公報記
載の方法においては、酵素量に対する水分量(0〜10
00%)に言及しているものの、実施例では反応系20
2.5g当たり2.5g(12,300ppm)という
多量の水分が用いられており、本発明者らが水分量につ
いて検討した結果、該水分量をγ−リノレン酸含有トリ
グリセリドに適用しても、トリグリセリド中の高度不飽
和脂肪酸の濃度が低く、未だ満足するものが得らないと
いうことが判明した。However, the method described in JP-A-63-273485 has a problem that a specific highly unsaturated fatty acid in triglyceride cannot be highly concentrated. 6-2875
No. 94, the oleic acid used for transesterification corresponds to the average molecular weight of the constituent fatty acids of fish oil, so that the content of γ-linolenic acid in triglycerides cannot be increased, and the content of triglycerides in the resulting fats and oils cannot be increased. The yield was not as high as about 90 mol% based on the raw material triglyceride. Further, in the method described in Japanese Patent Application Laid-Open No. 8-2144891, the amount of water (0 to 10
00%), the reaction system 20
As much as 2.5 g (12,300 ppm) of water is used per 2.5 g, and the present inventors have studied the amount of water. As a result, even if the amount of water is applied to γ-linolenic acid-containing triglyceride, It has been found that the concentration of polyunsaturated fatty acids in triglycerides is low and that no satisfactory ones can be obtained yet.
【0005】[0005]
【課題を解決するための手段】そこで、本発明者らは、
上記事情に鑑みて鋭意研究を行った結果、γ−リノレン
酸含有トリグリセリド及び/またはジホモγ−リノレン
酸含有トリグリセリドを含む油脂に、中鎖脂肪酸、及び
30〜500ppmの水の存在下で、トリグリセリドの
1,3−位のエステル結合のみに作用するリパーゼを反
応させることで、1,3−位に、γ−リノレン酸あるい
はジホモγ−リノレン酸等の高度不飽和脂肪酸よりも分
子量の小さい中鎖脂肪酸が導入され、2−位に存在して
いるγ−リノレン酸あるいはジホモγ−リノレン酸はそ
のまま保持されることにより、結果的にγ−リノレン
酸、ジホモγ−リノレン酸の含量が大きくなったトリグ
リセリド(以下γ−リノレン酸高度含有トリグリセリ
ド、ジホモγ−リノレン酸高度含有トリグリセリドと呼
ぶ)を収率よく、長期間連続的に製造することに成功
し、更に得られたトリグリセリドを含む油脂の保存安定
性が良いことを見いだし、本発明を完成するに至った。Means for Solving the Problems Accordingly, the present inventors have:
In view of the above circumstances, as a result of intensive research, fats and oils containing γ-linolenic acid-containing triglycerides and / or dihomo γ-linolenic acid-containing triglycerides, medium-chain fatty acids, and 30 to 500 ppm of water, in the presence of triglycerides By reacting a lipase acting only on the 1,3-position ester bond, a medium-chain fatty acid having a smaller molecular weight than a highly unsaturated fatty acid such as γ-linolenic acid or dihomoγ-linolenic acid at the 1,3-position Is introduced, and the γ-linolenic acid or dihomoγ-linolenic acid present at the 2-position is retained as it is, resulting in an increased content of γ-linolenic acid and dihomoγ-linolenic acid. (Hereinafter referred to as highly γ-linolenic acid-rich triglyceride, dihomo γ-linolenic acid highly-containing triglyceride) with good yield and continuous Succeeded in producing a further found that good storage stability of the fat or oil containing the resulting triglyceride, thereby completing the present invention.
【0006】以下、本発明を詳細に説明する。本発明に
おいては、γ−リノレン酸含有トリグリセリド及び/ま
たはジホモγ−リノレン酸含有トリグリセリド(以下原
料トリグリセリドと略記する)を含む油脂が用いられる
が、該油脂は、構成脂肪酸にγ−リノレン酸またはジホ
モγ−リノレン酸を含有するトリグリセリドを含むもの
で、例えば、菜種油、月見草油、黒すぐり油、ボラージ
油等の植物の他、さらに、クロレラ、スピルリナ等の藻
類、モルティエラ属の菌類から抽出した油脂等を挙げる
ことができる。Hereinafter, the present invention will be described in detail. In the present invention, fats and oils containing γ-linolenic acid-containing triglyceride and / or dihomo γ-linolenic acid-containing triglyceride (hereinafter abbreviated as raw material triglyceride) are used. It contains triglycerides containing γ-linolenic acid, and includes, for example, plants such as rapeseed oil, evening primrose oil, black currant oil, borage oil, chlorella, algae such as spirulina, oils and fats extracted from Mortierella spp. Can be mentioned.
【0007】本発明の中鎖脂肪酸としては、炭素数 6
〜12個を有する脂肪酸から選ばれるものであり、例え
ば、カプロン酸、カプリル酸、カプリン酸、ラウリル酸
等が挙げられるが、好ましくはカプリル酸、カプリン酸
が用いられる。[0007] The medium-chain fatty acid of the present invention has 6 carbon atoms.
These are selected from fatty acids having up to 12 fatty acids, such as caproic acid, caprylic acid, capric acid, and lauric acid. Of these, caprylic acid and capric acid are preferably used.
【0008】本発明で用いられるリパーゼとしては、例
えば、リゾプス(Rhizopus)属、リゾムコール
(Rhizomucor)属、アスペルギルス(Asp
ergillus)属などの微生物が生産するもの、ブ
タ膵臓リパーゼなどが挙げられる。かかるリパーゼにつ
いては、市販のものを用いることができる。例えば、リ
ゾプス・デレマー(Rhizopus delema
r)のリパーゼ(田辺製薬(株)製、『タリパー
ゼ』)、リゾムコール・ミイヘイ(Rhizomuco
r miehei)のリパーゼ(ノボ・ノルティスク
(株)社製、『リボザイムIM』)、アスペルギルス・
ニガー(Aspergillus niger)のリパ
ーゼ(天野製薬(株)、『リパーゼA』)等が挙げられ
る。The lipase used in the present invention includes, for example, genus Rhizopus, genus Rhizomucor, and Aspergillus (Asp.)
porcine pancreatic lipase, and the like. As such a lipase, a commercially available lipase can be used. For example, Rhizopus delema
r) lipase (“Taripase”, manufactured by Tanabe Seiyaku Co., Ltd.), Rhizomuco
rmiei) (Novo Nortisk Co., Ltd., “Ribozyme IM”), Aspergillus
Aspergillus niger lipase (Amano Pharmaceutical Co., Ltd., “Lipase A”) and the like.
【0009】また本発明においては、かかるリパーゼと
して固定化リパーゼを用いると、水分量を0にすること
ができるので、後述する反応系の水分量の調整の点で有
効である。In the present invention, when an immobilized lipase is used as such a lipase, the water content can be reduced to zero, which is effective in adjusting the water content of the reaction system described later.
【0010】固定化する担体としては、セライト、イオ
ン交換樹脂、セラミック等が挙げられるが、好ましく
は、セラミックが用いられ、セラミックの種類としては
セラミック担体SM−10(日本ガイシ(株)製)が好
ましいが、これに限定されるものではない。固定化リパ
ーゼを用いる場合、リパーゼ量は担体1g当たり100
〜2,000,000ユニット、好ましくは1,000
〜300,000ユニットである。The carrier to be immobilized includes celite, ion exchange resin, ceramic and the like. Preferably, ceramic is used. As the type of ceramic, ceramic carrier SM-10 (manufactured by NGK Insulators, Ltd.) is used. Preferred but not limiting. When immobilized lipase is used, the amount of lipase is 100 per gram of the carrier.
~ 2,000,000 units, preferably 1,000
~ 300,000 units.
【0011】リパーゼの固定化方法としては、特に限定
されないが、例えば、上記のユニット数のリパーゼを含
む0.1〜30重量%、好ましくは1.0〜20重量%
の蛋白質(リパーゼ)水溶液1〜100ml、好ましく
は10〜30mlに1〜10gのセラミック担体を懸濁
させ、緩く撹拌しながら、−20〜−80℃に冷却した
10〜300mlのアセトン、エタノールあるいはイソ
プロパノールを徐々に加え、リパーゼを固定化担体に吸
着させる。沈殿した画分を回収し、減圧条件下で十分乾
燥する。The method for immobilizing the lipase is not particularly limited. For example, 0.1 to 30% by weight, preferably 1.0 to 20% by weight, containing the above number of units of lipase.
1 to 100 ml, preferably 10 to 30 ml, of an aqueous solution of a protein (lipase) is suspended in 1 to 10 g of a ceramic carrier, and cooled to -20 to -80 ° C with gentle stirring, and 10 to 300 ml of acetone, ethanol or isopropanol is cooled. Is gradually added to adsorb the lipase to the immobilized carrier. The precipitated fraction is collected and dried sufficiently under reduced pressure.
【0012】次に固定化リパーゼの活性化を行う。バッ
チ法の場合、活性化は固定化酵素の10〜50倍容量の
油脂/中鎖脂肪酸/水〔30〜40:60〜70:1〜
5(重量比)〕中で、30℃、40時間振盪させながら
インキュベートする。カラム法の場合、活性化は固定化
酵素の1〜10倍量の、油脂/中鎖脂肪酸/水〔30〜
40:60〜70:5〜10(重量比)〕混合液を通液
し、通過液を再度カラムに添加する。この操作を合計で
1〜10サイクル行う。この際の流速は、圧損がなけれ
ばいくらでもよい。Next, the immobilized lipase is activated. In the case of the batch method, the activation is 10 to 50 times the volume of the immobilized enzyme by the amount of oil / fat / medium chain fatty acid / water [30 to 40:60 to 70: 1 to 1
5 (weight ratio)] at 30 ° C. with shaking for 40 hours. In the case of the column method, the activation is carried out in an amount of 1 to 10 times the amount of the immobilized enzyme, such as fat / medium chain fatty acid / water [30 to
40:60 to 70: 5 to 10 (weight ratio)], and then pass the mixed solution through the column again. This operation is performed for 1 to 10 cycles in total. The flow rate at this time may be any value as long as there is no pressure loss.
【0013】本発明の製造法では、リパーゼで原料トリ
グリセリド中の1,3−位の高度不飽和脂肪酸を中鎖脂
肪酸にエステル交換するのであるが、反応系中の原料ト
リグリセリドを含有する油脂の量としては10〜50重
量%、好ましくは15〜50重量%である。反応系中の
中鎖脂肪酸の量としては50〜90重量%、好ましくは
50〜85重量%であり、反応系中の原料トリグリセリ
ド/中鎖脂肪酸の重量比は1〜10が好ましく、更には
1〜5である。In the production method of the present invention, the 1,3-position polyunsaturated fatty acid in the starting triglyceride is transesterified into a medium-chain fatty acid by lipase, and the amount of fats and oils containing the starting triglyceride in the reaction system is reduced. Is 10 to 50% by weight, preferably 15 to 50% by weight. The amount of the medium-chain fatty acid in the reaction system is 50 to 90% by weight, preferably 50 to 85% by weight, and the weight ratio of the raw material triglyceride / medium-chain fatty acid in the reaction system is preferably 1 to 10, and more preferably 1 to 10. ~ 5.
【0014】リパーゼの反応系中の添加量は反応液1g
に対して4〜80,000ユニットが好ましく、更には
40〜8,000ユニットである。ここでの1ユニット
とは、オリーブ油を基質とし、1分間に1μモルの脂肪
酸を生成するのに必要なリパーゼ量を示す。The amount of lipase added to the reaction system is 1 g of the reaction solution.
Is preferably 4 to 80,000 units, and more preferably 40 to 8,000 units. Here, one unit refers to the amount of lipase required to produce 1 μmol of fatty acid per minute using olive oil as a substrate.
【0015】本発明では、かかる反応の際に、30〜5
00ppmの水の存在下で反応させることを最大の特徴
とするもので、好ましくは50〜150ppmである。
水が30ppm未満ではエステル交換が進行しにくくな
り、また、500ppmを越えると、酵素の安定性が悪
くなり、トリグリセリドの加水分解が起こるので好まし
くない。水は、リパーゼ、中鎖脂肪酸、原料トリグリセ
リドを含む油脂中に含まれるものでもよいが合計の水の
量が、30〜500ppmになる様にコントロールする
ことが必要であり、該コントロールの方法としては、
あらかじめ、各成分の水分量をカールフィッシャー法に
より測定しておき、合計の水分量をコントロールする方
法、反応成分を完全に脱水して、後で所定量の水を加
える方法等があるが、の方法が、粉末のリパーゼ等吸
湿性のあるものの取り扱いが簡略なので好ましい。なお
固定化リパーゼが保持している水分量は、本発明の水分
量には含めないものとする。In the present invention, 30 to 5
The most characteristic feature is that the reaction is carried out in the presence of 00 ppm of water, preferably 50 to 150 ppm.
If the amount of water is less than 30 ppm, transesterification hardly proceeds, while if it exceeds 500 ppm, the stability of the enzyme is deteriorated and the hydrolysis of triglyceride occurs, which is not preferable. Water may be contained in fats and oils containing lipase, medium-chain fatty acid, and raw material triglyceride, but it is necessary to control the total amount of water to be 30 to 500 ppm. ,
In advance, the water content of each component is measured by the Karl Fischer method, a method of controlling the total water content, a method of completely dehydrating the reaction components and adding a predetermined amount of water later, and the like. The method is preferred because the handling of powdery lipases and other hygroscopic materials is simple. The amount of water held by the immobilized lipase is not included in the amount of water of the present invention.
【0016】また、反応方法としては、バッチ法、カラ
ム法いずれも適用可能であるが、連続的に大量に反応が
可能、固液分離が容易であるのでカラム法が好ましい。As the reaction method, both the batch method and the column method can be applied, but the column method is preferred because the reaction can be continuously performed in large amounts and the solid-liquid separation is easy.
【0017】以下固定化リパーゼを使用した、カラム法
について説明するがこれに限定されるものではない。ま
ず、固定化酵素をカラムに充填し、固定化酵素の1〜1
0倍容量の油脂/中鎖脂肪酸/水〔30〜40:60〜
70:5〜10(重量比)〕混合液で上記の固定化リパ
ーゼの活性化の所で述べたように、合計4サイクル通液
し活性化する。ついで真空蒸留、脱水処理等により脱水
した原料トリグリセリドを含む油脂及び中鎖脂肪酸の各
水分量を測定し、必要があれば、水を所定量追加し、水
分量30〜500ppmとなるようにして、均一に撹拌
して反応原液を作製する。この反応原液を線速度0.5
〜1000ml/hr、好ましくは1〜10ml/h
r、空間速度0.01〜10/hr、好ましくは0.1
〜1/hrでカラムに通過させる。反応温度10〜60
℃、好ましくは15〜45℃である。Hereinafter, a column method using an immobilized lipase will be described, but the present invention is not limited thereto. First, the column is filled with the immobilized enzyme,
0 volumes of fats / oils / medium chain fatty acids / water [30-40: 60-
70: 5 to 10 (weight ratio)] As described in the section of the activation of the immobilized lipase, the mixture is passed through for a total of 4 cycles to activate. Then, each water content of fats and oils and medium-chain fatty acids containing raw material triglyceride dehydrated by vacuum distillation, dehydration treatment, etc. is measured, and if necessary, a predetermined amount of water is added so that the water content becomes 30 to 500 ppm, A homogeneous solution is prepared by stirring uniformly. This reaction stock solution was added at a linear velocity of 0.5
10001000 ml / hr, preferably 1-10 ml / h
r, space velocity 0.01 to 10 / hr, preferably 0.1
Pass through the column at 1 / 1 / hr. Reaction temperature 10-60
° C, preferably 15 to 45 ° C.
【0018】得られた通過液にアルカリを加えて、エス
テル交換させて生じた、遊離脂肪酸と交換されなかった
過剰の中鎖脂肪酸を中和させて脂肪酸塩とした後、水を
加えて、該脂肪酸塩を水層に抽出して、有機溶剤を加え
て、トリグリセリド(油層)を回収する。水層は反応系
にリサイクルして用いることも可能である。[0018] An alkali is added to the obtained passing solution to neutralize an excess medium-chain fatty acid which has not been exchanged with free fatty acids produced by transesterification to form a fatty acid salt, and then water is added. The fatty acid salt is extracted into the aqueous layer, and an organic solvent is added to recover the triglyceride (oil layer). The aqueous layer can be recycled for use in the reaction system.
【0019】上記エステル合成反応により、トリグリセ
リドは原料トリグリセリドに対して、93〜97モル%
回収することができ、またトリグリセリド中のγ−リノ
レン酸を28〜35重量%にジホモγ−リノレン酸を2
5〜36重量%とすることができる。By the above ester synthesis reaction, the triglyceride was 93 to 97 mol% based on the starting triglyceride.
It can be recovered, and γ-linolenic acid in triglyceride is 28 to 35% by weight and dihomo γ-linolenic acid is 2%.
It can be 5 to 36% by weight.
【0020】また、本発明では、上記のリパーゼの反応
において、ビタミンEを共存させることも好ましく、製
造したトリグリセリドを含有する油脂の保存安定性、取
扱性等の向上に寄与する。該ビタミンEとしては、α−
トコフェロール、β−トコフェロール、γ−トコフェロ
ール、δ−トコフェロール等のいずれかあるいは混合物
が用いられ、好ましくは小麦胚牙油等が挙げられる。In the present invention, it is also preferable to coexist with vitamin E in the above-mentioned lipase reaction, which contributes to the improvement of the storage stability, handleability and the like of the produced fat and oil containing triglyceride. As the vitamin E, α-
Any or a mixture of tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol and the like are used, and preferably, wheat germ oil and the like are used.
【0021】本発明で製造したトリグリセリドは、2−
位に多く含有するγ−リノレン酸あるいはジホモγ−リ
ノレン酸を全く遊離しないため、γ−リノレン酸あるい
はジホモγ−リノレン酸を高度に含有し、また本発明の
製造法では、上記のカラム法によるエステル交換反応を
連続的に行った場合、原料トリグリセリドに対して95
モル%以上の回収率で、トリグリセリドを得る反応を3
0〜200日程度連続運転することができる。更に得ら
れたトリグリセリドを含む油脂を、室温で長期間放置し
ても酸価の上昇が少なく、保存安定性がよい。The triglyceride produced according to the present invention is 2-triglyceride.
Γ-linolenic acid or dihomoγ-linolenic acid, which contains a large amount of γ-linolenic acid or dihomoγ-linolenic acid, contains a high amount of γ-linolenic acid or dihomoγ-linolenic acid, and the production method of the present invention uses the above-described column method. When the transesterification reaction is continuously performed, 95% of the starting triglyceride is used.
The reaction to obtain triglyceride with a recovery of at least
It can be operated continuously for about 0 to 200 days. Furthermore, even if the obtained fat or oil containing triglyceride is left at room temperature for a long period of time, the increase in the acid value is small and the storage stability is good.
【0022】[0022]
【実施例】以下、実施例により本発明をさらに具体的に
説明する。但し、本発明は、これら実施例に限定されな
い。なお「%」とあるのは脂肪酸組成をガスクロで分析
したピーク面積%を示す。 実施例1 セラミック担体SM−10〔日本ガイシ(株)製〕にリ
ゾプス デルマー(Rhizopus delema
r)のリパーゼ(田辺製薬社製、『タリパーゼ』5,0
00ユニット/担体g)8gを固定化した後、円筒形の
カラム(直径1.5cm、長さ6.2cm、容量10.
95cm3)に詰めた後、カラムの上端から、ボラージ
油〔トリグリセリド中のγ−リノレン酸22.2%、水
分量200ppm含有、ビタミンEとして小麦胚芽油
(エーザイ社製、『イーミックス』)0.2重量%〕
と、炭素数8の中鎖脂肪酸であるカプリル酸(水分量2
00ppm含有)の1:2(重量比)混合物〔原料トリ
グリセリド:カプリル酸=1:2(重量比)〕を、線速
度4ml/hr、空間速度0.589/hrで仕込みな
がら30℃でエステル交換連続反応を行った。得られた
反応液は、反応開始1日後と90日後に通過液3g分取
し、1N−水酸化ナトリウム水溶液を加えて中和し放置
後、水層(下層)を除去して、トリグリセリド層(上
層)をヘキサン抽出し、該ヘキサンを除去してグリセリ
ド画分を得た。該グリセリド画分を、ODSカラム(A
M120 S−50、YMC社製)で分析し、トリグリ
セリド画分は0.79gと算出された。得られたトリグ
リセリド画分を、常法によりメチルエステル化して、ト
リグリセリド中の脂肪酸組成をキャピラリークロマトグ
ラフィーで分析し、γ−リノレン酸は29.4%となっ
た〔原料トリグリセリド(γ−リノレン酸22.2%)
1gからトリグリセリド0.79g(γ−リノレン酸2
9.4%)が得られたので、トリグリセリドの回収率は
96モル%であった〕。又、該油脂1gを密封試験管に
入れ、室温で1カ月保存試験を行い、保存前、保存後の
酸価を基準油脂分析試験法により測定し、酸価の上昇を
測定し以下の様に評価した。 ◎・・・1mgKOH/油脂g未満 ○・・・1〜5mgKOH/油脂g未満 △・・・5〜10mgKOH/油脂g未満 ×・・・10mgKOH/油脂g以上 反応開始1日後の結果は表1に、90日後の結果は表2
に示す。The present invention will be described more specifically with reference to the following examples. However, the present invention is not limited to these examples. Note that “%” indicates the peak area% obtained by analyzing the fatty acid composition by gas chromatography. Example 1 A ceramic carrier SM-10 (manufactured by NGK Insulators, Ltd.) was used on Rhizopus delmera.
r) Lipase (Talipase 5,0 manufactured by Tanabe Seiyaku Co., Ltd.)
After immobilizing 8 g of (00 units / g of carrier), a cylindrical column (1.5 cm in diameter, 6.2 cm in length, capacity of 10.
After filling to 95 cm 3 ), borage oil [γ-linolenic acid in triglyceride: 22.2%, water content: 200 ppm, wheat germ oil as vitamin E (Eisai, “Emix”) 0 .2% by weight]
And caprylic acid, which is a medium-chain fatty acid having 8 carbon atoms (water content 2
Transesterification at 30 ° C. while charging a 1: 2 (weight ratio) mixture [raw material triglyceride: caprylic acid = 1: 2 (weight ratio)] at a linear velocity of 4 ml / hr and a space velocity of 0.589 / hr. A continuous reaction was performed. 1 day and 90 days after the start of the reaction, 3 g of the passing solution was collected, neutralized by adding a 1N aqueous solution of sodium hydroxide, allowed to stand, and the aqueous layer (lower layer) was removed to remove the triglyceride layer ( The upper layer was extracted with hexane, and the hexane was removed to obtain a glyceride fraction. The glyceride fraction was applied to an ODS column (A
M120 S-50, manufactured by YMC), and the triglyceride fraction was calculated to be 0.79 g. The obtained triglyceride fraction was subjected to methyl esterification by a conventional method, and the fatty acid composition in the triglyceride was analyzed by capillary chromatography. As a result, γ-linolenic acid was 29.4% [raw material triglyceride (γ-linolenic acid 22). .2%)
1 g to 0.79 g of triglyceride (γ-linolenic acid 2
9.4%), so the recovery of triglycerides was 96 mol%.] Also, 1 g of the fat or oil is placed in a sealed test tube, and a storage test is performed at room temperature for one month. Before and after storage, the acid value is measured by a standard fat and oil analysis test method, and the increase in acid value is measured as follows. evaluated. ◎ ・ ・ ・ 1mgKOH / less than oil g ○ ・ ・ ・ 1-5mgKOH / less than oil g △ ・ ・ ・ 5-10mg KOH / less than oil g × ・ ・ ・ 10mgKOH / g or more oil Table 2 shows the results after 90 days.
Shown in
【0023】実施例2 実施例1において、小麦胚芽油(エーザイ社製、『イー
ミックス』)を含まないボラージ油を用いた以外は同様
に反応して、同様に分析しγ−リノレン酸を29.0%
含有トリグリセリドを、原料ボラージ油に対して、回収
率94モル%で得た。保存試験も同様に行った。結果を
表1、2に示す。Example 2 The same reaction as in Example 1 was carried out except that borage oil containing no wheat germ oil (“Emix” manufactured by Eisai Co., Ltd.) was used. 0.0%
The contained triglyceride was obtained at a recovery of 94 mol% based on the raw material borage oil. A storage test was performed in the same manner. The results are shown in Tables 1 and 2.
【0024】実施例3 実施例1において、カプリル酸の替わりにカプリン酸
(水分量200ppm)を同重量用いて、同様に実施
し、同様に評価した。結果を表1、2に示す。Example 3 The same procedure as in Example 1 was repeated except that caprylic acid (water content: 200 ppm) was used in place of caprylic acid, and the same operation was performed, and the same evaluation was performed. The results are shown in Tables 1 and 2.
【0025】実施例4 実施例1において、ボラージ油の替わりに、モルティエ
ラ属抽出油(ジホモγ−リノレン酸16%含有)を用い
て、実施例1と同様に反応させ、実施例1と同様に評価
し、結果を表1、2に示した。Example 4 The procedure of Example 1 was repeated, except that instead of borage oil, Mortierella extracted oil (containing 16% of dihomo γ-linolenic acid) was used and reacted in the same manner as in Example 1. The results were evaluated and the results are shown in Tables 1 and 2.
【0026】実施例5 実施例2において、ボラージ油の替わりに、モルティエ
ラ属抽出油(ジホモγ−リノレン酸16%含有)を用い
て、実施例1と同様に反応させ、実施例1と同様に評価
し、結果を表1、2に示した。Example 5 In Example 2, a reaction was carried out in the same manner as in Example 1 except that an extract oil of the genus Mortierella (containing 16% of dihomo γ-linolenic acid) was used instead of borage oil, and the reaction was carried out in the same manner as in Example 1. The results were evaluated and the results are shown in Tables 1 and 2.
【0027】実施例6 実施例3において、ボラージ油の替わりに、モルティエ
ラ属抽出油(ジホモγ−リノレン酸16%含有)を用い
て、実施例1と同様に反応させ、実施例1と同様に評価
し、結果を表1、2に示した。Example 6 In Example 3, a reaction was carried out in the same manner as in Example 1 except that an extract oil of the genus Mortierella (containing 16% of dihomo γ-linolenic acid) was used instead of borage oil, and the reaction was carried out in the same manner as in Example 1. The results were evaluated and the results are shown in Tables 1 and 2.
【0028】比較例1 実施例1において、ボラージ油の水分量を10ppm
に、カプリル酸の水分量を10ppmのものを用いて、
実施例1と同様に反応させ、実施例1と同様に評価し、
結果を表1、2に示した。Comparative Example 1 In Example 1, the water content of borage oil was changed to 10 ppm.
In addition, using a water content of caprylic acid of 10 ppm,
The reaction was performed in the same manner as in Example 1, and the evaluation was performed in the same manner as in Example 1.
The results are shown in Tables 1 and 2.
【0029】比較例2 実施例1において、ボラージ油の水分量を1000pp
mに、カプリル酸の水分量を1000ppmのものを用
いて、実施例1と同様に反応させ、実施例1と同様に評
価し、結果を表1、2に示した。Comparative Example 2 In Example 1, the water content of the borage oil was changed to 1000 pp.
The reaction was carried out in the same manner as in Example 1 by using caprylic acid having a water content of 1000 ppm for m, and evaluated in the same manner as in Example 1. The results are shown in Tables 1 and 2.
【0030】[0030]
【表1】 トリグリセリド 保存試験 GLA(%) DGLA(%) トリク゛リセト゛ 原料 反応後 原料 反応後 回収率(モル%) 実施例1 22.2 29.4 −− −−− 96 ◎ 実施例2 22.2 29.0 −− −−− 94 ○ 実施例3 22.2 29.0 −− −−− 96 ◎ 実施例4 −− −− 16.0 25.3 95 ◎ 実施例5 −− −− 16.0 25.0 95 ◎実施例6 −− −− 16.0 25.0 95 ◎ 比較例1 22.0 28.5 −− −−− 98 ○比較例2 22.0 28.0 −− −−− 90 ○ [Table 1] Triglyceride preservation test GLA (%) DGLA (%) triglyceride raw material After reaction Raw material After reaction Recovery (mol%) Example 1 22.2 29.4----96 ◎ Example 2 22.2 29.0----- 94 ○ Example 3 22.2 29.0-----96 ◎ Example 4----16.0 25.3 95 ◎ Example 5----16.0 25.0 95 ◎ Example 6-----16.0 25.0 95 ◎ Comparative example 1 22.0 28.5 −− −−− 98 ○ Comparative Example 2 22.0 28.0 −− −−− 90 ○
【0031】[0031]
【表2】 トリグリセリド 保存試験 GLA(%) DGLA(%) トリク゛リセト゛ 原料 反応後 原料 反応後 回収率(モル%) 実施例1 22.2 29.2 −− −−− 95 ◎ 実施例2 22.2 29.0 −− −−− 94 ○ 実施例3 22.2 29.0 −− −−− 96 ◎ 実施例4 −− −− 16.0 25.3 95 ◎ 実施例5 −− −− 16.0 25.0 95 ◎ 実施例6 −− −− 16.0 25.0 95 ◎ 比較例1 22.0 22.2 −− −−− 100 ◎ 比較例2 22.0 23.0 −− −−− 75 ○ [Table 2] Triglyceride storage test GLA (%) DGLA (%) triglyceride raw material After reaction Raw material After reaction Recovery (mol%) Example 1 22.2 29.2----95 ◎ Example 2 22.2 29.0----- 94 ○ Example 3 22.2 29.0-----96 ◎ Example 4----16.0 25.3 95 ◎ Example 5----16.0 25.0 95 ◎ Example 6-----16.0 25.0 95 ◎ Comparative example 1 22.0 22.2 −− −−− 100 ◎ Comparative Example 2 22.0 23.0 −− −−− 75 ○
【0032】[0032]
【発明の効果】本発明では、γ−リノレン酸含有トリグ
リセリド及び/またはジホモγ−リノレン酸含有トリグ
リセリドを含む油脂に、中鎖脂肪酸、及び30〜500
ppmの水の存在下で、トリグリセリドの1,3−位の
エステル結合のみに作用するリパーゼを反応させるの
で、収率よく、該トリグリセリドが得られ、また固定化
リパーゼを用いてカラムで長期間連続的に反応させるこ
とが可能となり、更に得られたトリグリセリドを含む油
脂の保存安定性が良い。According to the present invention, medium-chain fatty acids and 30 to 500 g of fats and oils containing γ-linolenic acid-containing triglyceride and / or dihomo γ-linolenic acid-containing triglyceride are added.
In the presence of water of ppm, the lipase acting only on the ester bond at the 1,3-position of triglyceride is reacted, so that the triglyceride can be obtained in good yield, and the column can be continuously used for a long time using immobilized lipase. And the resulting oils and fats containing triglycerides have good storage stability.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 藤田 裕之 大阪府茨木市室山2丁目13番1号 日本合 成化学工業株式会社中央研究所内 (72)発明者 福嶋 信浩 大阪府茨木市室山2丁目13番1号 日本合 成化学工業株式会社中央研究所内 (72)発明者 山上 知秀 大阪市北区野崎町9番6号 日本合成化学 工業株式会社内 ──────────────────────────────────────────────────続 き Continuation of the front page (72) Hiroyuki Fujita, Inventor 2- 13-1, Muroyama, Ibaraki-shi, Osaka, Japan Inside the Central Research Laboratory of Nippon Gosei Chemical Industry Co., Ltd. (72) Inventor Nobuhiro Fukushima 2--13, Muroyama, Ibaraki-shi, Osaka No. 1 Nippon Kasei Chemical Co., Ltd. Central Research Laboratory (72) Inventor Tomohide Yamagami 9-6 Nozaki-cho, Kita-ku, Osaka
Claims (4)
またはジホモγ−リノレン酸含有トリグリセリドを含む
油脂に、中鎖脂肪酸、及び30〜500ppmの水の存
在下で、トリグリセリドの1,3−位のエステル結合の
みに作用するリパーゼを反応させることを特徴とするγ
−リノレン酸高度含有トリグリセリド及び/またはジホ
モγ−リノレン酸高度含有トリグリセリドを含む油脂の
製造法。(1) a γ-linolenic acid-containing triglyceride and / or
Or fats and oils containing dihomo γ-linolenic acid-containing triglyceride, in the presence of medium-chain fatty acid and 30 to 500 ppm of water, reacting a lipase acting only on the 1,3-position ester bond of triglyceride, Γ
-A method for producing fats and oils containing highly linolenic acid-rich triglycerides and / or highly di-homo-γ-linolenic acid-rich triglycerides.
徴とする請求項1記載のγ−リノレン酸高度含有トリグ
リセリド及び/またはジホモγ−リノレン酸高度含有ト
リグリセリドを含む油脂の製造法。2. The method according to claim 1, wherein the reaction is carried out in the presence of vitamin E. 3. The method for producing fats and oils containing highly γ-linolenic acid-rich triglycerides and / or highly di-homo γ-linolenic acid-rich triglycerides.
とを特徴とする請求項1または2記載のγ−リノレン酸
高度含有トリグリセリド及び/またはジホモγ−リノレ
ン酸高度含有トリグリセリドを含む油脂の製造法。3. The method according to claim 1, wherein immobilized lipase is used as the lipase. 3. The method according to claim 1, wherein the lipase comprises a highly γ-linolenic acid-rich triglyceride and / or a highly di-homo γ-linolenic acid-rich triglyceride.
またはジホモγ−リノレン酸含有トリグリセリドを含む
油脂が、植物、藻類又は菌類から抽出したものであるこ
とを特徴とする請求項1〜3いずれか記載のγ−リノレ
ン酸高度含有トリグリセリド及び/またはジホモγ−リ
ノレン酸高度含有トリグリセリドを含む油脂の製造法。4. A γ-linolenic acid-containing triglyceride and / or
Or the fat or oil containing dihomo-γ-linolenic acid-containing triglyceride is extracted from plants, algae or fungi, and the gamma-linolenic acid-rich triglyceride and / or dihomoγ according to any one of claims 1 to 3 -A method for producing an oil or fat containing a highly linolenic acid-containing triglyceride.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9116281A JPH10290699A (en) | 1997-04-18 | 1997-04-18 | Production of oil and fat containing triglyceride containing gamma-linolenic acid at high concentration and/or triglyceride containing dihomo-gamma-linolenic acid at high concentration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9116281A JPH10290699A (en) | 1997-04-18 | 1997-04-18 | Production of oil and fat containing triglyceride containing gamma-linolenic acid at high concentration and/or triglyceride containing dihomo-gamma-linolenic acid at high concentration |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10290699A true JPH10290699A (en) | 1998-11-04 |
Family
ID=14683197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9116281A Pending JPH10290699A (en) | 1997-04-18 | 1997-04-18 | Production of oil and fat containing triglyceride containing gamma-linolenic acid at high concentration and/or triglyceride containing dihomo-gamma-linolenic acid at high concentration |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH10290699A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1411129A1 (en) * | 2001-07-02 | 2004-04-21 | Suntory Limited | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid |
WO2004024930A3 (en) * | 2002-09-13 | 2004-07-08 | Suntory Ltd | Process for production of transesterified oils/fats or triglycerides |
-
1997
- 1997-04-18 JP JP9116281A patent/JPH10290699A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1411129A1 (en) * | 2001-07-02 | 2004-04-21 | Suntory Limited | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid |
EP1411129A4 (en) * | 2001-07-02 | 2005-07-06 | Suntory Ltd | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid |
US7538238B2 (en) | 2001-07-02 | 2009-05-26 | Suntory Limited | Production method of oil or fat containing polyunsaturated fatty acid-containing triglyceride |
US7767427B2 (en) | 2001-07-02 | 2010-08-03 | Suntory Holdings Limited | Production method of oil or fat containing polyunsaturated fatty acid-containing triglyceride |
WO2004024930A3 (en) * | 2002-09-13 | 2004-07-08 | Suntory Ltd | Process for production of transesterified oils/fats or triglycerides |
JP2007528191A (en) * | 2002-09-13 | 2007-10-11 | サントリー株式会社 | Process for producing transesterified oil or fat or triglyceride |
AU2003260967B2 (en) * | 2002-09-13 | 2009-12-10 | Suntory Holdings Limited | Process for production of transesterified oils/fats or triglycerides |
US7998712B2 (en) | 2002-09-13 | 2011-08-16 | Suntory Holdings Limited | Process for production of transesterified oils/fats or triglycerides |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2175030B1 (en) | Method for producing diacylglycerol-rich fat and/or oil | |
EP1500645B1 (en) | Astaxanthin medium-chain fatty acid ester, process for producing the same and composition containing the ester | |
US6040161A (en) | Low SAFA oils | |
KR20040030787A (en) | Process for producing fat comprising triglyceride contaninig highly unsaturated fatty acid | |
JP2719667B2 (en) | Method for producing transesterified fat | |
KR102373368B1 (en) | Preparation method of palmitoleic acid-enriched triglyceride using an enzyme | |
EP1792999B1 (en) | Process for the enzymatic synthesis of triglycerides | |
US20110076358A1 (en) | Process for producing diacylglycerol-rich fat or oil | |
JP3526632B2 (en) | Fats and oils containing highly unsaturated fatty acids | |
Choi et al. | Preparation of phytosteryl ester and simultaneous enrichment of stearidonic acid via lipase-catalyzed esterification | |
JPH10290699A (en) | Production of oil and fat containing triglyceride containing gamma-linolenic acid at high concentration and/or triglyceride containing dihomo-gamma-linolenic acid at high concentration | |
TWI774898B (en) | Vegetable-based lipid composition, paint or varnish comprising the same, and process for producing the same | |
JP3340182B2 (en) | Method for producing triglyceride containing docosahexaenoic acid | |
JP3853767B2 (en) | Conjugated fatty acid menthol ester and method for producing the same | |
JP2545480B2 (en) | Functional food material | |
JPH03103499A (en) | Production of highly unsaturated fatty acid monoglyceride | |
US20160361285A1 (en) | Method for purifying stearidonic acid | |
CN112752511A (en) | DHA enriched polyunsaturated fatty acid composition | |
CN112533483A (en) | DHA enriched polyunsaturated fatty acid composition | |
CN112533482A (en) | DHA enriched polyunsaturated fatty acid composition | |
JPH0466052A (en) | Salad oil | |
JP2570774B2 (en) | Oil and fat reforming method | |
JP2001245686A (en) | Method for producing fatty acid lower alcohol ester | |
JP2004222595A (en) | Method for producing diglyceride | |
JP2572692B2 (en) | Method for producing docosahexaenoic acid triglyceride |